Global AI Drug Development Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10251596

Publication Date:

October 16, 2024

Pages:

104

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global AI Drug Development market size was valued at US$ million in 2023. With growing demand in downstream market, the AI Drug Development is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AI Drug Development market. AI Drug Development are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AI Drug Development. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AI Drug Development market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on AI Drug Development market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the AI Drug Development market. It may include historical data, market segmentation by Type (e.g., Drug Design, Drug Synthesis), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AI Drug Development market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AI Drug Development market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AI Drug Development industry. This include advancements in AI Drug Development technology, AI Drug Development new entrants, AI Drug Development new investment, and other innovations that are shaping the future of AI Drug Development.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AI Drug Development market. It includes factors influencing customer ' purchasing decisions, preferences for AI Drug Development product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AI Drug Development market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AI Drug Development market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AI Drug Development market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AI Drug Development industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AI Drug Development market.
Market Segmentation:
AI Drug Development market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Drug Design
Drug Synthesis
Other
Segmentation by application
Tumor
Nervous System
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Insilico Medicine
Cyclica
XtalPi Inc.
Exscientia Limited
AiCure, LLC
Atomwise
Biovista Inc.
叠谤别驳锛孖苍肠.
Numerate
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI Drug Development Market Size 2019-2030
2.1.2 AI Drug Development Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AI Drug Development Segment by Type
2.2.1 Drug Design
2.2.2 Drug Synthesis
2.2.3 Other
2.3 AI Drug Development Market Size by Type
2.3.1 AI Drug Development Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI Drug Development Market Size Market Share by Type (2019-2024)
2.4 AI Drug Development Segment by Application
2.4.1 Tumor
2.4.2 Nervous System
2.4.3 Other
2.5 AI Drug Development Market Size by Application
2.5.1 AI Drug Development Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI Drug Development Market Size Market Share by Application (2019-2024)
3 AI Drug Development Market Size by Player
3.1 AI Drug Development Market Size Market Share by Players
3.1.1 Global AI Drug Development Revenue by Players (2019-2024)
3.1.2 Global AI Drug Development Revenue Market Share by Players (2019-2024)
3.2 Global AI Drug Development Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI Drug Development by Regions
4.1 AI Drug Development Market Size by Regions (2019-2024)
4.2 Americas AI Drug Development Market Size Growth (2019-2024)
4.3 APAC AI Drug Development Market Size Growth (2019-2024)
4.4 Europe AI Drug Development Market Size Growth (2019-2024)
4.5 Middle East & Africa AI Drug Development Market Size Growth (2019-2024)
5 Americas
5.1 Americas AI Drug Development Market Size by Country (2019-2024)
5.2 Americas AI Drug Development Market Size by Type (2019-2024)
5.3 Americas AI Drug Development Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Drug Development Market Size by Region (2019-2024)
6.2 APAC AI Drug Development Market Size by Type (2019-2024)
6.3 APAC AI Drug Development Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI Drug Development by Country (2019-2024)
7.2 Europe AI Drug Development Market Size by Type (2019-2024)
7.3 Europe AI Drug Development Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI Drug Development by Region (2019-2024)
8.2 Middle East & Africa AI Drug Development Market Size by Type (2019-2024)
8.3 Middle East & Africa AI Drug Development Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI Drug Development Market Forecast
10.1 Global AI Drug Development Forecast by Regions (2025-2030)
10.1.1 Global AI Drug Development Forecast by Regions (2025-2030)
10.1.2 Americas AI Drug Development Forecast
10.1.3 APAC AI Drug Development Forecast
10.1.4 Europe AI Drug Development Forecast
10.1.5 Middle East & Africa AI Drug Development Forecast
10.2 Americas AI Drug Development Forecast by Country (2025-2030)
10.2.1 United States AI Drug Development Market Forecast
10.2.2 Canada AI Drug Development Market Forecast
10.2.3 Mexico AI Drug Development Market Forecast
10.2.4 Brazil AI Drug Development Market Forecast
10.3 APAC AI Drug Development Forecast by Region (2025-2030)
10.3.1 China AI Drug Development Market Forecast
10.3.2 Japan AI Drug Development Market Forecast
10.3.3 Korea AI Drug Development Market Forecast
10.3.4 Southeast Asia AI Drug Development Market Forecast
10.3.5 India AI Drug Development Market Forecast
10.3.6 Australia AI Drug Development Market Forecast
10.4 Europe AI Drug Development Forecast by Country (2025-2030)
10.4.1 Germany AI Drug Development Market Forecast
10.4.2 France AI Drug Development Market Forecast
10.4.3 UK AI Drug Development Market Forecast
10.4.4 Italy AI Drug Development Market Forecast
10.4.5 Russia AI Drug Development Market Forecast
10.5 Middle East & Africa AI Drug Development Forecast by Region (2025-2030)
10.5.1 Egypt AI Drug Development Market Forecast
10.5.2 South Africa AI Drug Development Market Forecast
10.5.3 Israel AI Drug Development Market Forecast
10.5.4 Turkey AI Drug Development Market Forecast
10.5.5 GCC Countries AI Drug Development Market Forecast
10.6 Global AI Drug Development Forecast by Type (2025-2030)
10.7 Global AI Drug Development Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Information
11.1.2 Insilico Medicine AI Drug Development Product Offered
11.1.3 Insilico Medicine AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Insilico Medicine Main Business Overview
11.1.5 Insilico Medicine Latest Developments
11.2 Cyclica
11.2.1 Cyclica Company Information
11.2.2 Cyclica AI Drug Development Product Offered
11.2.3 Cyclica AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Cyclica Main Business Overview
11.2.5 Cyclica Latest Developments
11.3 XtalPi Inc.
11.3.1 XtalPi Inc. Company Information
11.3.2 XtalPi Inc. AI Drug Development Product Offered
11.3.3 XtalPi Inc. AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 XtalPi Inc. Main Business Overview
11.3.5 XtalPi Inc. Latest Developments
11.4 Exscientia Limited
11.4.1 Exscientia Limited Company Information
11.4.2 Exscientia Limited AI Drug Development Product Offered
11.4.3 Exscientia Limited AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Exscientia Limited Main Business Overview
11.4.5 Exscientia Limited Latest Developments
11.5 AiCure, LLC
11.5.1 AiCure, LLC Company Information
11.5.2 AiCure, LLC AI Drug Development Product Offered
11.5.3 AiCure, LLC AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AiCure, LLC Main Business Overview
11.5.5 AiCure, LLC Latest Developments
11.6 Atomwise
11.6.1 Atomwise Company Information
11.6.2 Atomwise AI Drug Development Product Offered
11.6.3 Atomwise AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Atomwise Main Business Overview
11.6.5 Atomwise Latest Developments
11.7 Biovista Inc.
11.7.1 Biovista Inc. Company Information
11.7.2 Biovista Inc. AI Drug Development Product Offered
11.7.3 Biovista Inc. AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biovista Inc. Main Business Overview
11.7.5 Biovista Inc. Latest Developments
11.8 叠谤别驳锛孖苍肠.
11.8.1 叠谤别驳锛孖苍肠. Company Information
11.8.2 叠谤别驳锛孖苍肠. AI Drug Development Product Offered
11.8.3 叠谤别驳锛孖苍肠. AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 叠谤别驳锛孖苍肠. Main Business Overview
11.8.5 叠谤别驳锛孖苍肠. Latest Developments
11.9 Numerate
11.9.1 Numerate Company Information
11.9.2 Numerate AI Drug Development Product Offered
11.9.3 Numerate AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Numerate Main Business Overview
11.9.5 Numerate Latest Developments
11.10 Cloud Pharmaceuticals
11.10.1 Cloud Pharmaceuticals Company Information
11.10.2 Cloud Pharmaceuticals AI Drug Development Product Offered
11.10.3 Cloud Pharmaceuticals AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Cloud Pharmaceuticals Main Business Overview
11.10.5 Cloud Pharmaceuticals Latest Developments
11.11 IBM
11.11.1 IBM Company Information
11.11.2 IBM AI Drug Development Product Offered
11.11.3 IBM AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 IBM Main Business Overview
11.11.5 IBM Latest Developments
11.12 NuMedii
11.12.1 NuMedii Company Information
11.12.2 NuMedii AI Drug Development Product Offered
11.12.3 NuMedii AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 NuMedii Main Business Overview
11.12.5 NuMedii Latest Developments
11.13 BenevolentAI
11.13.1 BenevolentAI Company Information
11.13.2 BenevolentAI AI Drug Development Product Offered
11.13.3 BenevolentAI AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 BenevolentAI Main Business Overview
11.13.5 BenevolentAI Latest Developments
11.14 Lam Therapeutics
11.14.1 Lam Therapeutics Company Information
11.14.2 Lam Therapeutics AI Drug Development Product Offered
11.14.3 Lam Therapeutics AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Lam Therapeutics Main Business Overview
11.14.5 Lam Therapeutics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂